Verition Fund Management LLC Amgen Inc Put Options Transaction History

Verition Fund Management LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $1.92 Million - $2.09 Million	-6,200 Reduced 79.49%	1,600 $515,000
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $1.68 Million - $2.04 Million	6,400 Added 457.14%	7,800 $2.44 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $295,757 - $357,016	-1,100 Reduced 44.0%	1,400 $398,000
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $1.53 Million - $1.73 Million	-6,000 Reduced 70.59%	2,500 $720,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $240,515 - $298,606	-1,100 Reduced 11.46%	8,500 $2.28 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $2.06 Million - $2.43 Million	9,600 New	9,600 $2.13 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $412,254 - $523,818	-1,800 Reduced 34.62%	3,400 $892,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1.17 Million - $1.32 Million	5,200 New	5,200 $1.17 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $942,861 - $1.04 Million	4,300 Added 126.47%	7,700 $1.86 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $676,192 - $773,840	3,400 New	3,400 $765,000

3,119

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.